Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphomaJonathan H. Schatz, Hans‐Guido Wendel|The Journal of Experimental Medicine|2011Cited by 114
Statins enhance efficacy of venetoclax in blood cancersJ. Scott Lee, Lee-or Herzog, Sharmila Mallya et al.|Science Translational Medicine|2018Cited by 86
TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumorsAmit Dipak Amin, Jonathan H. Schatz|Oncotarget|2016Cited by 22